Fairfield County cities: 6 companies received FDA inspections in Q3 2023

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) - Official Website
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) - Official Website
0Comments

There were six companies in cities associated with Fairfield County, Connecticut, that received six FDA inspections in the third quarter of 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 50% increase over the number of companies inspected in the previous quarter, when four companies received four inspections.

Most of the companies inspected at the time were involved in the Devices and Food and Cosmetics sectors. Both the Drugs and Biologics sectors sectors tied for second most common type.

There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Companies Located in Cities Within Fairfield County and Their Inspection Results
Company Name Area of Business Inspection Date Result
American Fertility Services Biologics 07/19/2023 No Action Indicated (NAI)
Conair, LLC Devices 07/19/2023 No Action Indicated (NAI)
Loxo Oncology, Inc. Drugs 09/15/2023 No Action Indicated (NAI)
New England Greens, LLC Food and Cosmetics 09/07/2023 Voluntary Action Indicated (VAI)
Reis & Son Import & Export Company Food and Cosmetics 08/31/2023 No Action Indicated (NAI)
Tarry Medical Products, Inc. Devices 09/27/2023 No Action Indicated (NAI)


Related

U.S. Rep. Jim Himes Serving Connecticut's 4th District

Jim Himes addresses Hungary’s leadership change and Trump-Zelenskyy call controversy

U.S. Congressman Jim Himes posted several tweets between April 11-13, commenting on political shifts in Hungary and reflecting on the controversy over Donald Trump’s phone call with Ukraine’s president.

U.S. Rep. Jim Himes Serving Connecticut's 4th District

Jim Himes criticizes Trump’s actions and calls for congressional debate over Iran conflict

U.S. Congressman Jim Himes posted a series of statements on April 7-8, criticizing President Donald Trump’s approach to the conflict with Iran and urging congressional debate before further military action.

U.S. Rep. Jim Himes Serving Connecticut's 4th District

Jim Himes comments on Gang of Eight expansion and economic impact after presidential speech

Congressman Jim Himes shared commentary on social media regarding both political humor around the “Gang of Eight” and serious concerns over rising oil prices after a presidential address on April 1-2, 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Bridgeport Times.